The company said Resorbable’s orthopedic biomaterials will complement its existing CellerateRx wound care products.
Read Wound Management Technologies’ release on its acquisition Resorbable Orthopedics.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
